Refreshing results…
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation
Download from doi.orgImmunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
Download from www.nature.comMissing publications? Search for publications with a matching author name.